Efficient Active Hydrogen Delivery for Drug-Free Radiation Enteritis Therapy

Luntao Liu,Xianggui Yin,Changfen Bi,Yuanfang Chen,Xueyin Hu,Guangyou Shi,Shuqin Li,Wen Zhang,Longbo Ma,Saijun Fan

DOI: https://doi.org/10.21203/rs.3.rs-5221636/v1

2024-01-01

Abstract:Radiation enteritis affects over 90% of patients undergoing pelvic or abdominal radiotherapy, primarily due to radiation-induced production of reactive oxygen and nitrogen species (RONS). Active hydrogens possess broad-spectrum RONS scavenging ability, demonstrating great potential in radioprotection. However, owing to the intestinal mucus barrier and short lifespan of active hydrogens, delivering active hydrogens to the injury site has been significantly challenging. Herein, drinkable, simple-structured, self-thermophoresis-powered sodium alginate-coated hydrogenated molybdenum oxide nanomachines with high capacity of active hydrogens (HxMoO3@SAs) were developed, featuring excellent directional motility driven by near-infrared (NIR) light and the ability to spontaneously and sustainably release of active hydrogens. Further, HxMoO3@SAs were innovatively applied in treating acute radiation enteritis. Their unique directional motion ability enables HxMoO3@SAs to successfully overcome the mucus barrier and prolong retention in the intestine, allowing the released active hydrogens to reach hard-to-reach injury sites, thereby achieving precise and efficient enteritis therapy. Surprisingly, in addition to highly efficient scavenging of cytotoxic RONS, the released hydrogen can also induce the polarization of macrophages into an anti-inflammatory phenotype, increase goblet cell abundance, and modulate the intestinal microbiota, leading to the repair of radiation-induced intestinal damage. Overall, this hydrogen-based, drug-free treatment strategy, coupled with precise delivery capability, presented superior efficacy in treating radiation enteritis.